HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Primary granulocytic sarcoma of the pancreas: efficacy of early treatment with intensive chemotherapy].

Abstract
In the absence of systemic chemotherapy after the diagnosis of primary granulocytic sarcoma (PGS), all patients will subsequently develop acute myelogenous leukemia (AML). The authors describe a case of PGS of the head of the pancreas found at laparotomy in a 32-year-old man. The patient received early after surgery, two courses of high-dose chemotherapy and, with a follow-up of 2 years, never developed AML. This rare observation illustrates the necessity of further early systemic chemotherapy after surgical excision of PGS.
AuthorsP Moreau, N Milpied, O Thomas, M Fiche, V Parys, J Paineau, J P Dutin, J L Harousseau
JournalLa Revue de medecine interne (Rev Med Interne) Vol. 17 Issue 8 Pg. 677-9 ( 1996) ISSN: 0248-8663 [Print] France
Vernacular TitleSarcome granulocytique primitif du pancréas: efficacité d'un traitement précoce par chimiothérapie intensive.
PMID8881197 (Publication Type: Case Reports, English Abstract, Journal Article, Review)
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Humans
  • Leukemia, Myeloid (drug therapy)
  • Male
  • Pancreatic Neoplasms (drug therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: